FSD Pharma Inc. (HUGE)

FSD Pharma Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019	2018	2017
Cash & Equivalents	2.76	16.98	35.26	17.52	5.97	15.9	4.74
Short-Term Investments	7.94	0.02	0.16	0	0	0	0
Cash & Cash Equivalents	10.7	17	35.42	17.52	5.97	15.9	4.74
Cash Growth	-37.07%	-51.99%	102.10%	193.66%	-62.47%	235.44%	-
Receivables	0.23	0.37	0.5	0.16	1.56	0.75	0
Inventory	0	0	0	0	0.71	0	0
Other Current Assets	0.16	0.47	1.37	0.57	0.32	0.33	0.65
Total Current Assets	11.09	17.85	37.29	18.26	8.56	16.98	5.39
Property, Plant & Equipment	0.12	0.26	0.17	0	8.98	9.32	8.29
Long-Term Investments	0.91	8.26	0.66	1.68	8.86	13.59	0
Goodwill and Intangibles	5.36	12.04	16.2	13.42	16.82	0	0
Other Long-Term Assets	0	0	8.65	8.61	0	0	0
Total Long-Term Assets	6.39	20.56	25.68	23.71	34.66	22.91	8.29
Total Assets	17.47	38.41	62.96	41.97	43.22	39.89	13.68
Accounts Payable	4.2	7.11	7.51	3.7	3.36	1.31	1.27
Current Debt	0.34	0.48	0.42	0.43	1.48	0.04	0
Other Current Liabilities	0.03	0.24	0.77	1.45	1.99	0	0
Total Current Liabilities	4.57	7.83	8.7	5.58	6.83	1.35	1.27
Long-Term Debt	0	0.04	0.13	0.08	0.11	0.14	0
Total Long-Term Liabilities	0	0.04	0.13	0.08	0.11	0.14	0
Total Liabilities	4.57	7.87	8.83	5.66	6.94	1.5	1.27
Total Debt	0.34	0.52	0.56	0.51	1.59	0.18	0
Debt Growth	-34.32%	-7.10%	8.87%	-67.85%	765.93%	-	-
Retained Earnings	-157.91	-144.16	-126.15	-90.87	-59.07	-19.94	-4.2
Comprehensive Income	0.42	0.65	0.24	0.21	-0.08	0	0
Shareholders' Equity	13.24	30.54	54.13	36.31	36.28	38.39	12.41
Net Cash / Debt	10.36	16.49	34.86	17.01	4.38	15.72	4.74
Net Cash / Debt Growth	-37.15%	-52.71%	104.90%	288.50%	-72.13%	231.57%	-
Net Cash Per Share	0.26	0.43	1.00	1.41	0.62	2.66	-
Working Capital	6.52	10.02	28.58	12.68	1.73	15.63	4.12
Book Value Per Share	0.33	0.79	1.55	3.02	5.14	6.50	5.67

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).